218 related articles for article (PubMed ID: 10087545)
1. Efficacy and safety of clonazepam in refractory neurally mediated syncope.
Kadri NN; Hee TT; Rovang KS; Mohiuddin SM; Ryan T; Ashraf R; Huebert V; Hilleman DE
Pacing Clin Electrophysiol; 1999 Feb; 22(2):307-14. PubMed ID: 10087545
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.
Morillo CA; Leitch JW; Yee R; Klein GJ
J Am Coll Cardiol; 1993 Dec; 22(7):1843-8. PubMed ID: 8245337
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of metoprolol vs clonazepam as a first treatment choice among patients with neurocardiogenic syncope].
Márquez MF; Urias-Medina K; Gómez-Flores J; Sobrino A; Sotomayor-González A; González-Hermosillo A; Cárdenas M
Gac Med Mex; 2008; 144(6):503-7. PubMed ID: 19112723
[TBL] [Abstract][Full Text] [Related]
4. The medical therapy of cardioinhibitory syncope in pediatric patients.
Deal BJ; Strieper M; Scagliotti D; Hulse E; Auld D; Campbell R; Strasburger JF; Benson DW
Pacing Clin Electrophysiol; 1997 Jul; 20(7):1759-61. PubMed ID: 9249828
[TBL] [Abstract][Full Text] [Related]
5. Situational syncope: response to head-up tilt testing and follow-up: comparison with vasovagal syncope.
Livanis EG; Leftheriotis D; Theodorakis GN; Flevari P; Zarvalis E; Kolokathis F; Kremastinos DT
Pacing Clin Electrophysiol; 2004 Jul; 27(7):918-23. PubMed ID: 15271010
[TBL] [Abstract][Full Text] [Related]
6. Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation.
Benditt DG
Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):572-84. PubMed ID: 9058856
[TBL] [Abstract][Full Text] [Related]
7. Potential risk of vasovagal syncope for motor vehicle driving.
Li H; Weitzel M; Easley A; Barrington W; Windle J
Am J Cardiol; 2000 Jan; 85(2):184-6. PubMed ID: 10955374
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of curative effect and serum electrolytes between different oral rehydration salts in treatment of neurally mediated syncope children].
Zhang W; Zou R; Xu Y; Wang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):537-543. PubMed ID: 29886470
[TBL] [Abstract][Full Text] [Related]
9. The relationship between neurally mediated hypotension and the chronic fatigue syndrome.
Bou-Holaigah I; Rowe PC; Kan J; Calkins H
JAMA; 1995 Sep; 274(12):961-7. PubMed ID: 7674527
[TBL] [Abstract][Full Text] [Related]
10. Study of the efficiency of the head-up tilt test with nitroglycerin challenge in the diagnosis of vasovagal syncope.
Podoleanu C; Frigy A; Dobreanu D; Micu S; Podoleanu D; Incze A; Caraşca E
Rom J Intern Med; 2004; 42(3):585-94. PubMed ID: 16366132
[TBL] [Abstract][Full Text] [Related]
11. Strategy for the management of vasovagal syncope.
Bloomfield DM
Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
[TBL] [Abstract][Full Text] [Related]
12. Syncope in athletes: a guide to getting them back on their feet.
Verma S; Hackel JG; Torrisi DJ; Nguyen T
J Fam Pract; 2007 Jul; 56(7):545-50. PubMed ID: 17605946
[No Abstract] [Full Text] [Related]
13. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of very low frequency at spectral analysis among patients with unexplained syncope assessed by head-up tilt testing.
Ciliberti MAP; Santoro F; Di Martino LFM; Rinaldi AC; Salvemini G; Cipriani F; Triggiani AI; Moscatelli F; Valenzano A; Di Biase M; Brunetti ND; Cibelli G
Arch Cardiovasc Dis; 2018 Feb; 111(2):95-100. PubMed ID: 28958870
[TBL] [Abstract][Full Text] [Related]
15. Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up.
Tajdini M; Aminorroaya A; Rahimi B; Mortazavi SH; Vasheghani Farahani A; Sadeghian S; Easapour Moghadam M; Soltani D; Bozorgi A
J Interv Card Electrophysiol; 2021 Jan; 60(1):31-39. PubMed ID: 31907833
[TBL] [Abstract][Full Text] [Related]
16. Medical therapy of neurocardiogenic syncope.
Cadman CS
Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
[TBL] [Abstract][Full Text] [Related]
17. A patient responding to combined therapy with pirmenol and midodrine for refractory neurally mediated syncope complicated by prostatic hypertrophy.
Mizuguchi Y; Ishimoto T; Kageyama N; Oishi Y; Emi S; Nagase N; Oki T
Cardiovasc Drugs Ther; 2004 Sep; 18(5):405-8. PubMed ID: 15717144
[TBL] [Abstract][Full Text] [Related]
18. The effects of gender and test protocol on the results of head-up tilt test in patients with vasovagal syncope.
Pietrucha A; Wojewódka-Zak E; Wnuk M; Wegrzynowska M; Bzukała I; Nessler J; Mroczek-Czernecka D; Piwowarska W
Kardiol Pol; 2009 Aug; 67(8A):1029-34. PubMed ID: 19784908
[TBL] [Abstract][Full Text] [Related]
19. Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study.
Palmisano P; Dell'Era G; Russo V; Zaccaria M; Mangia R; Bortnik M; De Vecchi F; Giubertoni A; Patti F; Magnani A; Nigro G; Rago A; Occhetta E; Accogli M
Europace; 2018 May; 20(5):859-866. PubMed ID: 28407148
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.
Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M
J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
